| Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients M Peghin, A Palese, M Venturini, M De Martino, V Gerussi, E Graziano, ... Clinical Microbiology and Infection 27 (10), 1507-1513, 2021 | 276 | 2021 |
| Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control M Bassetti, E Righi, A Carnelutti, E Graziano, A Russo Expert review of anti-infective therapy 16 (10), 749-761, 2018 | 172 | 2018 |
| Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae M Falcone, M Bassetti, G Tiseo, C Giordano, E Nencini, A Russo, ... Critical Care 24, 1-12, 2020 | 163 | 2020 |
| Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience M Bassetti, N Castaldo, A Cattelan, C Mussini, E Righi, C Tascini, ... International journal of antimicrobial agents 53 (4), 408-415, 2019 | 140 | 2019 |
| Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/extensively drug-resistant/pandrug-resistant bacteria M Bassetti, E Righi, A Vena, E Graziano, A Russo, M Peghin Current opinion in critical care 24 (5), 385-393, 2018 | 128 | 2018 |
| Vaccine hesitancy among Italian patients recovered from COVID-19 infection towards influenza and Sars-Cov-2 vaccination V Gerussi, M Peghin, A Palese, V Bressan, E Visintini, G Bontempo, ... Vaccines 9 (2), 172, 2021 | 92 | 2021 |
| Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study M Giannella, R Pascale, A Toschi, G Ferraro, E Graziano, F Furii, ... Clinical Microbiology and Infection 24 (10), 1077-1083, 2018 | 59 | 2018 |
| The fall in antibody response to SARS-CoV-2: a longitudinal study of asymptomatic to critically ill patients up to 10 months after recovery M Peghin, M De Martino, M Fabris, A Palese, E Visintini, E Graziano, ... Journal of Clinical Microbiology 59 (11), 10.1128/jcm. 01138-21, 2021 | 45 | 2021 |
| Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients M Peghin, M De Martino, A Palese, V Gerussi, G Bontempo, E Graziano, ... Clinical Microbiology and Infection 28 (8), 1140-1148, 2022 | 40 | 2022 |
| MR-proADM as prognostic factor of outcome in COVID-19 patients E Sozio, C Tascini, M Fabris, F D’Aurizio, C De Carlo, E Graziano, F Bassi, ... Scientific reports 11 (1), 5121, 2021 | 36 | 2021 |
| The role of fosfomycin for multidrug-resistant gram-negative infections M Bassetti, E Graziano, M Berruti, DR Giacobbe Current opinion in infectious diseases 32 (6), 617-625, 2019 | 34 | 2019 |
| Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant Pseudomonas aeruginosa A Vena, DR Giacobbe, C Mussini, A Cattelan, M Bassetti Clinical Infectious Diseases 71 (7), 1799-1801, 2020 | 28 | 2020 |
| Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study M Giannella, M Freire, M Rinaldi, E Abdala, A Rubin, A Mularoni, ... Clinical infectious diseases 73 (4), e955-e966, 2021 | 25 | 2021 |
| Management of vertebral osteomyelitis over an eight-year period: The UDIPROVE (UDIne PROtocol on VErtebral osteomyelitis) A Russo, E Graziano, A Carnelutti, M Sponza, B Cadeo, A Sartor, E Righi, ... International Journal of Infectious Diseases 89, 116-121, 2019 | 25 | 2019 |
| Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19 M Peghin, E Bouza, M Fabris, M De Martino, A Palese, G Bontempo, ... European Journal of Clinical Microbiology & Infectious Diseases 40, 2597-2604, 2021 | 24 | 2021 |
| Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with COVID-19 pneumonia: a prospective study A Da Porto, C Tascini, M Peghin, E Sozio, G Colussi, V Casarsa, ... Nutrients 13 (11), 4085, 2021 | 17 | 2021 |
| Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study M Giannella, E Graziano, L Marconi, N Girometti, M Bartoletti, S Tedeschi, ... European Journal of Clinical Microbiology & Infectious Diseases 36 (10 …, 2017 | 16 | 2017 |
| The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia E Graziano, M Peghin, M De Martino, C De Carlo, A Da Porto, L Bulfone, ... Clinical Nutrition ESPEN 51, 437-444, 2022 | 13 | 2022 |
| Vaccine hesitancy among Italian patients recovered from COVID-19 infection towards influenza and sars-Cov-2 vaccination. Vaccines. 2021; 9: 172 V Gerussi, M Peghin, A Palese, V Bressan, E Visintini, G Bontempo, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 13 | 2021 |
| Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain M Bassetti, A Russo, C Cilloniz, DR Giacobbe, A Vena, R Amaro, ... International journal of antimicrobial agents 55 (4), 105921, 2020 | 13 | 2020 |
